International conference on

Gene Therapy and Genetic Engineering

Theme: Transforming Medicine: Innovations and Challenges in Gene Therapy and Genetic Engineering
 

August 18-19, 2025 | Zurich, Switzerland

Gene Therapy Genetic Engineering Conference

Gene Therapy and Genetic Engineering Conference 2025

Gene Therapy Genetic Engineering Conference We’re excited to invite you to join us for the Gene Therapy and Genetic Engineering in Ophthalmology Conference, where we’ll dive into the cutting-edge world of genetic advancements in eye care. Gene Therapy Genetic Engineering Conference This conference offers a unique opportunity to connect with fellow professionals at the International Conference, explore the latest breakthroughs, and discuss how genetic therapies are transforming the treatment of ocular diseases.

Join many of the Optometry, ophthalmologists, optometrists, eye surgeons, eye care specialists, physicians, radiologists, medical imaging specialists, clinical researchers’ scientists, professors, ophthalmology equipment companies, medical practitioners, diagnostic instruments in optometry, and all the professionals from various multispecialty areas as they come together to share, partake research ideas, explore new collaborative, build career beginnings and witness the finest of the ophthalmology research community has to offer.

Scientific Sessions

Gene therapy involves altering or repairing genes within a patient’s cells to treat or cure genetic disorders. Gene Therapy Genetic Engineering Conference Imagine a dedicated team of scientists and doctors working together to deliver this cutting-edge treatment, aiming to fix the root cause of a condition.

Lecithin-retinol acyltransferase (LRAT) is an enzyme crucial for converting vitamin A into a form that the body can use for vision and skin health. Gene Therapy Conference Imagine a dedicated researcher studying this enzyme to understand its role in maintaining clear vision and healthy tissues.

RNA interference (RNAi) is a process that blocks specific genes from producing unwanted proteins, offering a powerful way to control gene expression. Gene Therapy Conference Imagine scientists using this technique to target and silence problematic genes, potentially treating diseases at their genetic source.

Glaucoma is a condition where increased pressure inside the eye can damage the optic nerve, leading to vision loss. Genetic Engineering conference Imagine a caring eye doctor carefully monitoring and treating this condition to protect your sight. International Conference Through regular check-ups and personalized treatments hey aim to manage the pressure and preserve your vision.

Retinitis pigmentosa is a genetic condition that causes progressive loss of vision due to the gradual degeneration of the retina. Gene Therapy conference Imagine a dedicated eye specialist providing support and treatment to help manage the symptoms.

Age-related macular degeneration (AMD) is a condition that affects the central part of the retina, leading to a gradual loss of sharp, central vision. Imagine a caring eye doctor working to diagnose and treat AMD with advanced therapies.

Genetic pediatric eye diseases are inherited conditions affecting children’s vision, often causing issues like retinopathy or congenital cataracts. Genetic Engineering Conference Imagine a compassionate eye specialist working closely with families to diagnose and manage these conditions.

Leber congenital amaurosis is a rare genetic condition present from birth that causes severe vision loss or blindness. Gene Therapy Conference Imagine a devoted eye care team working tirelessly to diagnose and manage this condition with cutting-edge treatments and support.

X-linked retinitis pigmentosa is a genetic condition where the retina slowly deteriorates, leading to vision loss and is inherited through the X chromosome. Imagine a caring eye specialist providing support and treatment to manage this progressive disease.

Achromatopsia is a rare condition where individuals are unable to perceive color and may also experience light sensitivity and poor vision. International Conference Imagine a dedicated eye care team working to understand and manage this condition with personalized support and adaptive tools.

X-linked retinoschisis is a genetic eye disorder causing the retina to split into layers, Genetic Engineering Conference leads to vision problems like reduced visual acuity and potential vision loss. Imagine a devoted eye specialist diagnosing and managing this condition with personalized care.

Retinal gene therapy is a cutting-edge treatment that introduces healthy genes into the retina to address genetic eye disorders. Gene Therapy Conference Imagine a compassionate team of researchers and doctors working together to deliver this precise therapy, aiming to restore vision and enhance quality of life.

Retinal degeneration is a condition where the retina gradually deteriorates, leading to vision loss over time. International Conference Imagine a devoted eye specialist guiding you through the diagnosis and treatment options with empathy and care.

CRISPR gene editing is a revolutionary technology that allows scientists to precisely alter DNA to correct genetic disorders. Picture a team of researchers using this tool to carefully edit faulty genes, offering new hope for treating diseases at their source.

The genetics of ocular diseases explore how inherited genes affect eye health, leading to conditions ranging from common to rare. International Conference Imagine a dedicated geneticist working to decode these genetic links with care and precision.

Ophthalmic genetics and gene therapy focus on understanding genetic factors in eye diseases and developing treatments to correct them. Genetic Engineering Conference Imagine a team of compassionate scientists and doctors working together to decode genetic information and apply advanced gene therapy techniques.

Genetic eye diseases are inherited conditions that affect vision, ranging from gradual vision loss to more severe impairment. Gene Therapy Conference Imagine a dedicated eye specialist carefully diagnosing these conditions and providing tailored treatments.

Stargardt disease is a genetic condition that causes progressive loss of central vision due to retinal degeneration. International Conference Imagine a dedicated eye specialist working closely with patients to diagnose and manage this condition.

Speakers

Sergey V. Suchkov

Astrakhan State Medical University

Mikhail Ostrovsky

Russian Academy of Sciences, Russia

Edward Charles Kondrot

Ophthalmologist, United States

Huma Saigol

Fatima Jinnah Medical University, Pakistan

khalifa Mohamed Ali Alsawidi

Tripoli University, Tripoli

Why to attend

The Gene Therapy and Genetic Engineering Conference 2025 conference bridges the gap between open-access publications and global international science conference events. Gene Therapy Conference It provides a platform for participants to showcase their research among world-renowned doctors, scientists, and professors.  Genetic Engineering Conference This event offers an exceptional opportunity for young researchers to engage, learn, and collaborate. Organized by Conference Series LLC LTD, the conference features well-structured scientific sessions, plenary lectures, poster presentations, world-class exhibitions, diverse symposiums, enriching workshops, and B2B meetings.

Targeted Audience

Conference Venue

Zurich stands as Switzerland’s largest city and is recognized as a key financial and cultural center. Situated in the heart of the nation, Zurich is celebrated for its robust economy, outstanding quality of life, and considerable global impact. The city features a well-developed infrastructure and is distinguished by its contributions to finance, technology, the arts, and education. The dynamic cultural landscape of Zurich encompasses a wide array of museums, galleries, and historical landmarks. Among its prominent sites are the Grossmünster Church, the Swiss National Museum, and the charming Old Town (Altstadt), known for its medieval architecture. Additionally, Zurich is renowned for the stunning Lake Zurich and the surrounding Alpine vistas, which create a harmonious blend of urban elegance and natural splendor.

Get Directions to the Event Venue

frequently asked questions

Abstracts can be submitted by researchers, clinicians, healthcare professionals, and students involved in Gene Therapy.

The deadline for abstract submission is Feb 12, 2025. No late submissions will be accepted.

Abstracts must be submitted online through the conference website. You will need to create an account on the submission portal and follow the instructions provided.

Yes, you can submit multiple abstracts. Each abstract must be submitted separately.

Abstracts must be no longer than 300 words and structured into four sections: Background, Methods, Results, and Conclusions. The title should be no more than 20 words.

Yes, you will receive an email confirmation once your abstract has been successfully submitted. 

All abstracts undergo a peer-review process by the Conference Scientific Committee. They are evaluated based on originality, significance, and clarity. Accepted abstracts will be selected for either oral or poster presentations

Notifications of acceptance will be sent within 24-48 hours of business days.

Accepted abstracts can be presented as either oral presentations or poster presentations. Oral presentations are 25 minutes long, including Q&A. Posters should be 36 inches x 48 inches in size.

Yes, outstanding abstracts will be recognized with awards in the following categories: Best Oral Presentation, Best Poster Presentation, and Young Investigator Award.

Media partners